Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04539002 · ClinicalTrials.gov registry record · Phase 1
Aerobic Exercise for Remyelination in Multiple Sclerosis
A Phase 1 study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- Phase 1
- Development phase
- 60
- Enrollment target
NCT04539002: Completed Phase 1 study, sponsored by Oregon Health and Science University.
NCT04539002 is a Phase 1 study that has completed, run by Oregon Health and Science University. The registered enrollment target is 60 participants, roughly in line with the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04539002, a Phase 1 study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 60 participants
- Enrollment target
Study Summary
This is a clinical trial to determine the feasibility of a stationary aerobic cycling intervention and explore if aerobic exercise independently promotes remyelination in people with multiple sclerosis (MS).
Primary Outcome
Measure of functional myelination of the somatosensory tracts of the spinal cord
Interventions
- BEHAVIORAL Aerobic exercise
- BEHAVIORAL Education Group Control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2021-04-29 |
| Est. Completion | 2025-03-27 |
| Phase | Phase 1 |
What the finished NCT04539002 record still lists
NCT04539002 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, roughly in line with the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target.
The record links to 0 conditions, and to 2 interventions - of which Aerobic exercise is the first listed.
NCT04539002 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04539002 about?
NCT04539002 is a clinical study titled "Aerobic Exercise for Remyelination in Multiple Sclerosis". This is a clinical trial to determine the feasibility of a stationary aerobic cycling intervention and explore if aerobic exercise independently promotes remyelination in people with multiple sclerosis (MS).
What is the current status of trial NCT04539002?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2021-04-29. Estimated completion is 2025-03-27.
What interventions are being tested in trial NCT04539002?
The interventions under investigation include: Aerobic exercise (BEHAVIORAL), Education Group Control (BEHAVIORAL).
Who is sponsoring clinical trial NCT04539002?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04539002's enrollment target sits among peer trials
60 831st of 2000 higher than 1,106 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI